glp1 and semaglutide Another Weight-Loss Trial Win for Weekly GLP-1 Drug Is Semaglutide GLP-1 Safe for
Description
Intestinal dysbiosis is associated with local and systemic inflammation, contributing to the pathogenesis of various diseases, including obesity, diabetes, and neurodegenerative disorders
Heally providers can assist with access and guidance
doi: 10.3810/pgm.1998.11.426
Patients with missing demographic data (age or sex), type 1 DM, 30, missing baseline eGFR data, and those with a follow-up period 50%, and progression to ESKD with dialysis
